Prolonged Strait of Hormuz standoff will close in on America's generic drug prescriptions

50% of US generic drugs are manufactured in India and transit the Strait of Hormuz, creating a concentrated geopolitical chokepoint. Supply chains maintain emergency plans but prescription stockpiles are limited, raising meaningful risk of shortages and price pressure for generics if shipping or regional tensions disrupt flows.

Analysis

50% of US generic drugs are manufactured in India and transit the Strait of Hormuz, creating a concentrated geopolitical chokepoint. Supply chains maintain emergency plans but prescription stockpiles are limited, raising meaningful risk of shortages and price pressure for generics if shipping or regional tensions disrupt flows.